Pharmacologic strategies to reduce cardiovascular disease in type 2 diabetes mellitus: focus on SGLT-2 inhibitors and GLP-1 receptor agonists
published in: Journal of Internal Medicine
date of publication: 2019-03-19
main subject: type 2 diabetes, cardiovascular disease
Cites articles
There is nothing here
Article - wd:Q92472181